Pharmafile Logo
Pharmafocus logo
Advanced Search

New agreement gives AstraZeneca full responsibility for Linzess in China

September 18, 2019
Research and Development AstraZeneca, IBS-C, Linzess

AstraZeneca has amended its collaboration agreement with Ironwood Pharmaceuticals in China for Linzess (linaclotide), a first-in-class new treatment for patients …

News
versantis_square_nc_s-e1552579323179

Swiss biotech raises $16m for ‘undelivery mechanism’ in rare liver disease

September 18, 2019
Research and Development liver disease, versantis

A new method from Swiss Biotech Versantis promises to give far better immediate care and offer a treatment for a …

News
roche

Roche bags FDA Breakthrough for Gazyva in lupus nephritis

September 18, 2019
Research and Development FDA, Gazyva, Roche, lupus nephritis

The US FDA has granted Breakthrough Therapy Designation to Gazyva (obinutuzumab) for adults with lupus nephritis. The win comes on …

News
appg

New APPG report on access to cutting edge medicines

September 17, 2019
Manufacturing and Production

A new report from the All-Party Parliamentary Groups (APPG) is urging the life science community to work together to speed …

News

UKRI Chief Executive Sir Mark Walport to step down in 2020

September 17, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UKRI, appointment, pharma

Sir Mark Walport, Chief Executive of UK Research and Innovation (UKRI), the national funding agency responsible for science and research …

Appointment
common cold

New experimental approach could stop common cold

September 17, 2019
Manufacturing and Production, Research and Development

Scientists believe they may have found a way to stop the common cold as instead of attacking the virus directly, …

News
shutterstock_212432119

Acceleron terminates drug candidate following facioscapulohumeral muscular dystrophy failure

September 17, 2019
Manufacturing and Production, Research and Development Acceleron, pharma, trial failure

Acceleron Pharma has seen its stock fall by almost 4% after it unveiled new Phase 2 data confirming that its …

News

Enlarged prostate drug may slow Parkinson’s disease

September 17, 2019
Manufacturing and Production, Research and Development Parkinson's, terazosin

A surprising find has led researchers to see that a drug used to treat enlarged prostates may also work as …

News

Novartis’ Cosentyx has strong Phase 3 interim showing in axial spondyloarthritis

September 17, 2019
Manufacturing and Production, Research and Development Cosentyx, Novartis, pharma

Novartis has highlighted new data from its ongoing Phase 3 trial into the efficacy and safety of itsinterleukin-17A inhibitor Cosentyx …

News
jerome-carle-general-manager-of-julphar-photo-aetos-wire

Jerome Carle steps down as Julphar Chief Executive

September 16, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Chief Executive of Gulf Pharmaceutical Industries, Jerome Carle, is stepping down from his post at the United Arab Emirates drug …

Appointment
lung_ambition_alliance

Breaking through limits in lung cancer: Introducing The Lung Ambition Alliance

September 16, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, Lung Ambition Alliance, lung cancer, oncology, pharma

Patrick Connor, VP and Global Franchise Head, Tumor Drivers and Resistance Mechanisms, at AstraZeneca, discusses his company’s role in the …

Feature
OxyContin

Opioid drugmaker Purdue Pharma files for bankruptcy

September 16, 2019
Sales and Marketing OxyContin, Purdue Pharma

In the face of thousands of lawsuits in its role in the opioid addiction crisis, Purdue Pharma   announced yesterday that …

News
peanuts_nuts_snack_nutrition_healthy_nibble_decoration_close-842313

Aimmune’s peanut allergy therapy recommended for approval by FDA committee

September 16, 2019
Sales and Marketing Aimmune, FDA, peanut allergy, pharma

The FDA’s Allergenic Products Advisory Committee (APAC) has recommended the use of Aimmune Therapeutics’ AR101, also known by its proposed …

News

Lundbeck acquires Alder in $2bn migraine treatment move

September 16, 2019
Sales and Marketing Alder, Lundbeck, eptinezumab, migraine

Lundbeck is to buy Alder Biopharmaceuticals for $2 billion enhancing its leading portfolio of brain disease therapies through the acquisition …

News
amgen_flag

Amgen’s Kyprolis + Darzalex combo shows progression-free survival benefit in multiple myeloma

September 16, 2019
Research and Development, Sales and Marketing Amgen, Kyrpolis, darzalex, multiple myeloma, pharma

Amgen has revealed new Phase 3 data for the combination of Kyprolis (carfilzomib) and Darzalex (daratumumab) in addition to the …

News

Novartis announce robust Phase 3 trials for ofatumumab in MS

September 16, 2019
Research and Development, Sales and Marketing Aubagio, Novartis, multiple sclerosis

Novartis’ multiple sclerosis candidate has demonstrated strong results in its Phase 3 ASCLEPIOS trials meeting primary endpoints and slashing the …

News

Multi-study data confirms Ocrevus’ long-term efficacy in reducing disability progression in multiple sclerosis

September 13, 2019
Medical Communications, Research and Development ECTRIMS, Ocrevus, Roche, multiple sclerosis, pharma

Roche has taken the opportunity at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) conference in Stockholm …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 13, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

It’s Friday again and time for another rundown of the top most popular articles on Pharmafile.com this week. This past …

News

UKRI Chief Executive Sir Mark Walport to step down in 2020

September 13, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UKRI, appointment, pharma

Sir Mark Walport, Chief Executive of UK Research and Innovation (UKRI), the national funding agency responsible for science and research …

News
laura_fraser

General Pharmaceutical Council appoints Laura Fraser as director for Scotland

September 12, 2019

The General Pharmaceutical Council has appointed Laura Fraser, former clinical fellow for the Scottish Chief Pharmaceutical Officer as the new …

Appointment
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026